Abstract
The antimalarial drug, pyrimethamine is not used any more for the treatment of malaria due to the resistance phenomenon, though, it can be modified for the potential reuse in medicinal chemistry. The current research article is about the possibility of obtaining novel form of the drug with better drug delivery properties by the preparation of new pyrimethamine-based organic salt: 2,4-diamino-5-(4-chlorophenyl)-6-ethylpyrimidin-1-ium 2,4-dichlorobenzoate (1:1) (DECB). The salt was prepared via neutralization reaction utilizing pyrimethamine and 2,4-dichlorobenzoic acid as the base and acid components respectively. The structure of the salt was confirmed by the single crystal analysis. The single crystal X-ray diffraction (SC-XRD) investigation shows that strong N-H…O and comparatively weak C-H…π bonding are responsible for crystal packing forming the infinite 3D network. Hirshfeld surface analysis proposes high reactivity due to unequal distribution of the intermolecular interactions. The high chemical reactivity was confirmed by performing the density functional theory (DFT) calculations that showed high electrophilic properties of the DECB.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.